DBDCB as a future-proof alternative to isothiazolinones.
With the exclusive LANXESS active DBDCB, IMPAG offers a future-oriented alternative to the conventional isothiazolinones. There is no H317 or EUH 208 in the relevant application concentrations, and it is free of sensitizing substances despite having a broad spectrum of activity.
Further information can be found in the following Product Data Sheet: Preventol DP 18 (PDF)